Will the CheckMate 204 data affect clinicians?

Will the CheckMate 204 data affect clinicians?

moasc

2 months
11 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

John Fruehauf, MD disucsses whether the CheckMate 204 data will affect treatment selection in brain metastases

Up Next Autoplay
Determination from the FDA
Determination from the FDA
Category: Prostate Cancer
6 Views
moasc 2 months
The Role of Nephrectomy
The Role of Nephrectomy
Category: Kidney Cancer
3 Views
moasc 2 months
ENZAMET and TITAN Study
ENZAMET and TITAN Study
Category: Acute Lymphoblastic Leukemia
14 Views
moasc 2 months
CheckMate 204 Study
CheckMate 204 Study
Category: Melanoma and Skin Cancer
11 Views
moasc 2 months
Clinicians could change the way they manage their patients
Clinicians could change the way they manage their patients
Category: Melanoma and Skin Cancer
3 Views
moasc 2 months
Fixing toxic therapy
Fixing toxic therapy
Category: Melanoma and Skin Cancer
8 Views
moasc 2 months
Alternate dosing for immunotherapy
Alternate dosing for immunotherapy
Category: Melanoma and Skin Cancer
2 Views
moasc 2 months
Is this data practice changing for clinicians?
Is this data practice changing for clinicians?
Category: Melanoma and Skin Cancer
1 Views
moasc 2 months
IMNC Data
IMNC Data
Category: Melanoma and Skin Cancer
4 Views
moasc 2 months